Best International Stock: Syneron Medical
10434
This stock could keep you and your portfolio both looking young and healthy.
180751
A broad portfolio of drugs helps French pharmaceutical stay ahead of its peers.
519119
Looking for great stocks? Look beyond the U.S. borders.
82032
To turn its new multiple sclerosis treatment Antegren into a blockbuster drug with more than $1 billion in annual sales, Biogen Idec and its partner, Elan Pharmaceuticals, might not have to persuade doctors that it is superior to existing interferon treatments. Partial data released by the companies appear to confirm the treatment's outstanding clinical performance.
443776
Five stocks in the health-care sector that are poised for growth.
189872
Iamgold, a Canadian mining company, said that it would buy Cambior, a rival, for about 1.33 billion Canadian dollars ($1.2 billion) in stock, to create a gold mining operation with more than one million ounces of annual production. The deal will push Iamgold to the top of the midtier gold producers and comes six months after the miner bought Gallery Gold of Australia. ÂWe believe it sets the stage for us to join the senior ranks as we move forward in this company,Â IamgoldÂs chief executive, Joe Conway, left, said.
238851
Genzyme Corp.  said on Friday  its osteoarthritis pain treatment Synvisc will retain a  separate, higher reimbursement rate, after the U.S. government  reversed its earlier decision to cut the rate, sending Genzyme  shares higher.
112584
Medarex (Nasdaq: MEDX) is best known for being a leader in antibody technology with its capabilities for generating human antibodies in mice.
438480
Credit Suisse First Boston said that an announcement from Onyx Pharmaceuticals (nasdaq: ONXX - news - people ) is &quot;good news&quot; for Genentech (nyse: DNA - news - people ) and its Avastin treatment.
284180
LONDON (AFX) - Smiths Group PLC, the UK aerospace-to-medical-products maker, is in advanced talks to buy US healthcare group Medex for close to 1 bln usd (517 mln stg) the Sunday Telegraph reported without citing its source.
178334
The Motley Fool - Pharmaceutical investors often forget that places beyond the United States and European Union have their own regulatory bodies that approve drugs -- and that some of these markets can be quite lucrative. Canada, Japan, and Australia are home to some of the biggest economies in the world, and they all have their own independent drug-regulation entities.
671813
Syngenta announced today that it is selling its 75 per cent stake in the Swiss chemical company SF-Chem to the Zurich-based private equity firm Capvis.
47275
After 18 months of rancor, Oracle makes PeopleSoft an offer it can't refuse.  Also: IBM, AMD find ways to boost the performance of silicon chips & hellip;.  Survey ranks the most IT savvy countries; U.S. slips to 7th place & hellip;. and more.
571699
"There is nothing to answer because there is nothing on the table"  French food group Danone offered 12.3 billion euros for Dutch rival Numico to forge what it said would be the world's largest health and nutrition company. via Sympatico Finance
104489
Shares in pharmaceutical company Elan soared in early trading this morning after a newspaper report that US company Biogen was considering a bid for the company.
519863
The company faces a pivotal clinical trial.
257983
What's better than a high quality stock? A high quality stock that's got the wind at its back!